Tiziana Announces Initiation of Phase 1b Clinical Trial in Crohn’s Disease Patients to Evaluate Oral Capsules of Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody
This clinical trial, the first-ever oral immunotherapy for patients with mild-to-moderately active Crohn’s Disease, is…